137 related articles for article (PubMed ID: 37737611)
1. Cell-intrinsic and -extrinsic effects of SARS-CoV-2 RNA on pathogenesis: single-cell meta-analysis.
Khatun MS; Remcho TP; Qin X; Kolls JK
mSphere; 2023 Oct; 8(5):e0037523. PubMed ID: 37737611
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice.
Choi S; Lee J; Kim S; Lee YW; Kim GC; Hong SM; An SH; Noh H; Kim KE; On D; Lee SG; Jang HJ; Kim SH; Kim J; Seo JS; Kim JJ; Park IH; Oh J; Kim DJ; Yoon JH; Seok SH; Lee YJ; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Park JW; Yun JW; Shin JS; Seo JY; Nam KT; Choi KS; Kwon HK; Lee HY; Kim JK; Seong JK
EBioMedicine; 2024 Jan; 99():104932. PubMed ID: 38118400
[TBL] [Abstract][Full Text] [Related]
3. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
[TBL] [Abstract][Full Text] [Related]
5. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
6. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
7. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
8. Experimental Models of COVID-19.
Caldera-Crespo LA; Paidas MJ; Roy S; Schulman CI; Kenyon NS; Daunert S; Jayakumar AR
Front Cell Infect Microbiol; 2021; 11():792584. PubMed ID: 35096645
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
10. A Meta-Analysis of Rhesus Macaques (
Witt AN; Green RD; Winterborn AN
Comp Med; 2021 Oct; 71(5):433-441. PubMed ID: 34588096
[TBL] [Abstract][Full Text] [Related]
11. Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2.
Yu P; Deng W; Bao L; Qu Y; Xu Y; Zhao W; Han Y; Qin C
Vet Pathol; 2022 Jul; 59(4):602-612. PubMed ID: 35094625
[TBL] [Abstract][Full Text] [Related]
12. Animal Models of COVID-19: Transgenic Mouse Model.
Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.
Jeong H; Woo Lee Y; Park IH; Noh H; Kim SH; Kim J; Jeon D; Jang HJ; Oh J; On D; Uhm C; Cho K; Oh H; Yoon S; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Yeon Kim S; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Nam KT; Seong JK
Dis Model Mech; 2022 Nov; 15(11):. PubMed ID: 36222118
[TBL] [Abstract][Full Text] [Related]
14. Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models.
Dhanushkodi NR; Prakash S; Quadiri A; Zayou L; Srivastava R; Shaik AM; Suzer B; Ibraim IC; Landucci G; Tifrea DF; Singer M; Jamal L; Edwards RA; Vahed H; Brown L; BenMohamed L
J Immunol; 2024 Feb; 212(4):576-585. PubMed ID: 38180084
[TBL] [Abstract][Full Text] [Related]
15. Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
bioRxiv; 2021 Nov; ():. PubMed ID: 34816260
[TBL] [Abstract][Full Text] [Related]
16. Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2.
Monchatre-Leroy E; Lesellier S; Wasniewski M; Picard-Meyer E; Richomme C; Boué F; Lacôte S; Murri S; Pulido C; Vulin J; Salguero FJ; Gouilh MA; Servat A; Marianneau P
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33612147
[TBL] [Abstract][Full Text] [Related]
17. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
18. Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single-cell RNA sequencing.
Cohen P; DeGrace EJ; Danziger O; Patel RS; Barrall EA; Bobrowski T; Kehrer T; Cupic A; Miorin L; García-Sastre A; Rosenberg BR
Microbiol Spectr; 2023 Sep; 11(5):e0077623. PubMed ID: 37676044
[TBL] [Abstract][Full Text] [Related]
19. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.
Tiwari S; Goel G; Kumar A
Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923
[TBL] [Abstract][Full Text] [Related]
20. Animal Models of COVID-19 II. Comparative Immunology.
Veenhuis RT; Zeiss CJ
ILAR J; 2021 Dec; 62(1-2):17-34. PubMed ID: 33914873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
